Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Oliver, Kölbl"'
Autor:
Anna Fischl, Michael Gerken, Patricia Lindberg-Scharf, Tareq M. Haedenkamp, Katharina Rosengarth, Andrea Hillberg, Martin Vogelhuber, Ingrid Schön, Martin Proescholdt, Tommaso Araceli, Michael Koller, Anne Herrmann, Oliver Kölbl, Tobias Pukrop, Markus J. Riemenschneider, Nils Ole Schmidt, Monika Klinkhammer-Schalke, Ralf Linker, Peter Hau, Elisabeth Bumes
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 6155-6170 (2024)
(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate dehydrogenase wild-typ
Externí odkaz:
https://doaj.org/article/b6d4fc0de4c74cbc827356647324a854
Autor:
Sebastian H. Maier, Stephan Schönecker, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Daniel F. Fleischmann, Marcel Büttner, David Kaul, Detlef Imhoff, Emmanouil Fokas, Clemens Seidel, Peter Hau, Oliver Kölbl, Ilinca Popp, Anca-Ligia Grosu, Jan Haussmann, Wilfried Budach, Eren Celik, Klaus-Henning Kahl, Elgin Hoffmann, Ghazaleh Tabatabai, Frank Paulsen, Adrien Holzgreve, Nathalie L. Albert, Ulrich Mansmann, Stefanie Corradini, Claus Belka, Maximilian Niyazi, Raphael Bodensohn
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100790- (2024)
Background: The PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06; NCT05871021) is designed to determine whether a dose escalation with 75.0 Gy in 30 fractions can enhance the median overall survival (OS) in patients with methylguanine methyltransferase (M
Externí odkaz:
https://doaj.org/article/e593b5076b1b4d3582a15845aa79e307
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julia Lorenz, Tanja Rothhammer-Hampl, Saida Zoubaa, Elisabeth Bumes, Tobias Pukrop, Oliver Kölbl, Selim Corbacioglu, Nils O. Schmidt, Martin Proescholdt, Peter Hau, Markus J. Riemenschneider
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-15 (2020)
Abstract Recent updates in the classification of central nervous system (CNS) tumors have increased the need for molecular testing. Assessment of multiple alterations in parallel, complex combinations of gene sequence and chromosomal changes, as well
Externí odkaz:
https://doaj.org/article/430d4af534e348c3b9b1dea1af301bbe
Autor:
Eva-Marie Bichlmayer, Lina Mahl, Leo Hesse, Eric Pion, Victoria Haller, Andreas Moehwald, Christina Hackl, Jens M. Werner, Hans J. Schlitt, Siegfried Schwarz, Philipp Kainz, Christoph Brochhausen, Christian Groeger, Felix Steger, Oliver Kölbl, Christoph Daniel, Kerstin Amann, Andre Kraus, Björn Buchholz, Thiha Aung, Silke Haerteis
Publikováno v:
Cells, Vol 11, Iss 15, p 2269 (2022)
(1) Background: Autosomal dominant polycystic kidney disease (ADPKD) is a frequent monogenic disorder that leads to progressive renal cyst growth and renal failure. Strategies to inhibit cyst growth in non-human cyst models have often failed in clini
Externí odkaz:
https://doaj.org/article/967e3c069b3840c58825ec2058e7217b
Autor:
Anna Fischl, Michael Gerken, Philipp Roos, Tareq Haedenkamp, Andrea Hillberg, Monika Klinkhammer-Schalke, Oliver Kölbl, Ralf Linker, Martin Proescholdt, Tobias Pukrop, Markus J Riemenschneider, Nils Ole Schmidt, Ingrid Schön, Martin Vogelhuber, Peter Hau, Elisabeth Bumes
Publikováno v:
Neuro-Oncology Practice.
s Background Malignant isocitrate dehydrogenase wild-type (IDHwt) gliomas impose a high symptomatic and psychological burden. Wide distances from patients’ homes to cancer centers may affect the delivery of psycho-oncological care. Here, we investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f42f36eec6b133f24ccfbde4c336d2f
https://doi.org/10.1093/nop/npad023
https://doi.org/10.1093/nop/npad023
Autor:
Christoph Süß, Oliver Kölbl
Publikováno v:
InFo Hämatologie + Onkologie. 24:22-24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c5ec2e731643fc25a29191b63c18404
https://doi.org/10.1007/s15004-021-8888-z
https://doi.org/10.1007/s15004-021-8888-z
Autor:
Michael Anapolski, Elisabeth C. Inwald, Atanas Ignatov, Thomas Papathemelis, Sophia Scharl, Anton Scharl, Michael Gerken, Olaf Ortmann, Monika Klinkhammer-Schalke, Oliver Kölbl, Cornelia Becher
Publikováno v:
Archives of Gynecology and Obstetrics. 304:759-771
Due to insufficient and conflicting prospective evidence, the recommendations on when to apply adjuvant radiochemotherapy in early-stage cervical cancer vary between international guidelines. In this population-based study, we evaluated the outcome o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9218a520bcf1caea4ead91169b1f8fb
https://doi.org/10.1007/s00404-021-05989-w
https://doi.org/10.1007/s00404-021-05989-w
Autor:
Sophia Scharl, Tim Sprötge, Michael Gerken, Anton Scharl, Olaf Ortmann, Oliver Kölbl, Monika Klinkhammer‑Schalke, Thomas Papathemelis
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose Data from randomized controlled trials in high-grade endometrial cancer are scarce due to its low prevalence. Therefore, guideline recommendations in this cancer subtype rely on relatively few randomized trials and data from retrospective stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e71e973d548e78b947d924b11c98f4a
https://pubmed.ncbi.nlm.nih.gov/36239795
https://pubmed.ncbi.nlm.nih.gov/36239795
Autor:
Olaf Gefeller, Peter Breinl, Christian Rübe, Attila Salay, Oliver Kölbl, Claus Rödel, Dorota Lubgan, Heinrich Iro, Matthias G. Hautmann, Rainer Fietkau, Markus Hecht, Gerhard G. Grabenbauer, Panagiotis Balermpas, Ulrike Schreck, Patrick Melchior, Benjamin Hofner, Waldemar Krings, Barbara Wollenberg, Birgit Siekmeyer, Rainer Keerl, Stephan Gripp
Publikováno v:
Radiotherapy and Oncology. 144:209-217
Background and purpose This multicenter, phase 3 trial investigates whether the incorporation of concurrent paclitaxel and cisplatin together with a reduced total dose of radiotherapy is superior to standard fluorouracil–cisplatin based CRT. Materi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de8f2671a7aea3788c90e6d12cf59a7
https://doi.org/10.1016/j.radonc.2020.01.016
https://doi.org/10.1016/j.radonc.2020.01.016